1. Home
  2. TSEM vs CYTK Comparison

TSEM vs CYTK Comparison

Compare TSEM & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSEM
  • CYTK
  • Stock Information
  • Founded
  • TSEM 1993
  • CYTK 1997
  • Country
  • TSEM Israel
  • CYTK United States
  • Employees
  • TSEM N/A
  • CYTK N/A
  • Industry
  • TSEM Semiconductors
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSEM Technology
  • CYTK Health Care
  • Exchange
  • TSEM Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • TSEM 5.3B
  • CYTK 4.4B
  • IPO Year
  • TSEM 1994
  • CYTK 2004
  • Fundamental
  • Price
  • TSEM $46.65
  • CYTK $36.18
  • Analyst Decision
  • TSEM Strong Buy
  • CYTK Buy
  • Analyst Count
  • TSEM 3
  • CYTK 14
  • Target Price
  • TSEM $60.00
  • CYTK $70.92
  • AVG Volume (30 Days)
  • TSEM 785.1K
  • CYTK 1.3M
  • Earning Date
  • TSEM 08-04-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • TSEM N/A
  • CYTK N/A
  • EPS Growth
  • TSEM N/A
  • CYTK N/A
  • EPS
  • TSEM 1.80
  • CYTK N/A
  • Revenue
  • TSEM $1,467,054,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • TSEM $10.37
  • CYTK $27.08
  • Revenue Next Year
  • TSEM $11.10
  • CYTK $652.09
  • P/E Ratio
  • TSEM $26.58
  • CYTK N/A
  • Revenue Growth
  • TSEM 5.22
  • CYTK 412.21
  • 52 Week Low
  • TSEM $28.64
  • CYTK $29.31
  • 52 Week High
  • TSEM $55.31
  • CYTK $61.27
  • Technical
  • Relative Strength Index (RSI)
  • TSEM 54.28
  • CYTK 50.74
  • Support Level
  • TSEM $46.45
  • CYTK $36.71
  • Resistance Level
  • TSEM $48.94
  • CYTK $38.54
  • Average True Range (ATR)
  • TSEM 1.71
  • CYTK 1.32
  • MACD
  • TSEM -0.20
  • CYTK -0.27
  • Stochastic Oscillator
  • TSEM 36.02
  • CYTK 13.87

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: